Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial. Apr 2010 - :1477-2566 [PMID:20429791] [Trepiakas R] [Berntsen A] [Hadrup SR] [Bjørn J] [Geertsen PF] [Straten PT] [Andersen MH] [Pedersen AE] [Soleimani A] [Lorentzen T] [Johansen JS] [Svane IM]
Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2. Apr 2010 - J. Immunother.; 33(4):1537-4513 [PMID:20386464] [Berntsen A] [Brimnes MK] [thor Straten P] [Svane IM]
Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate. Oct 2009 - Scand. J. Immunol.; 70(5):1365-3083 [PMID:19874553] [Soleimani A] [Berntsen A] [Svane IM] [Pedersen AE]
Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial. Sep 2008 - J. Immunother.; 31(8):1537-4513 [PMID:18779742] [Berntsen A] [Trepiakas R] [Wenandy L] [Geertsen PF] [thor Straten P] [Andersen MH] [Pedersen AE] [Claesson MH] [Lorentzen T] [Johansen JS] [Svane IM]
Therapeutic dendritic cell vaccination of patients with renal cell carcinoma. Jun 2006 - Eur. Urol.; 50(1):0302-2838 [PMID:16675096] [Berntsen A] [Geertsen PF] [Svane IM]
